With the calendar flipped to June, the transfer window for non-graduate transfers is officially open, making the start of what is now one of the sport’s most critical and fast-moving markets. Several ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results